In addition, by analyzing the 53 cases of nuclear FOXP3-positive breast cancer samples, we found that there was no statistically significant difference between the expression of nuclear Gal-1 and breast carcinoma characteristics, such as age, clinical stages, ER status, and PR status (Supplementary Table 4). The gene discussed is FOXP3; the disease is breast cancer.